Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for treatment of heart failure
IRCT2015101924597N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of spironolactone in heart failure (HF), sponsored by Iran University of Medical Sciences. Started Aug 2015; status: completed.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on IRCT2015101924597N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015101924597N1.